Navigation Links
Waters Corporation Announces U.S. Drug Enforcement Administration Acquires Waters ACQUITY UPLC System to Train Forensic Chemists in Drug Screening and Profiling
Date:4/29/2009

MILFORD, Mass., April 29 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT) announced today that the United States Drug Enforcement Administration (U.S. DEA) purchased a Waters(R) ACQUITY(R) UltraPerformance Liquid Chromatograph for the purpose of training new forensic chemists at the Special Testing and Research Laboratory in Dulles, Va.

Forensic laboratories are an important resource in assisting local, state and federal law enforcement agencies in monitoring and combating illicit drug abuse and trafficking, including the diversion of legally-manufactured pharmaceuticals into illegal markets. For example, data collected by the DEA from forensic laboratories about the regional use of prescription pain medicines like oxycodone and hydrocodone for non-medical purposes informs drug policy and drug enforcement initiatives and helps solve crimes. Each year, several million seized drug items are analyzed by the nation's network of government and private forensic laboratories.

Since 2004, the DEA has applied Waters ACQUITY UltraPerformance LC(R) (UPLC(R)) technology for drug profiling and has investigated this technology for drug screening analyses.

For drug profiling applications, where experts analyze trace impurities such as precursor chemicals in synthetic drugs or the constituents of natural products such as those derived from opium, a combination of UPLC and mass spectrometry (UPLC/MS/MS) has been shown to offer 2X better resolving power than HPLC and greater specificity and sensitivity than HPLC paired with photodiode array detection. These trace impurities can be important in matching a seized drug to a particular individual and potentially linking it to other cases where a similar impurity profile has been generated.

The DEA's most recent acquisition of an ACQUITY UPLC System complements its growing number of Waters ACQUITY UPLC and UPLC/MS/MS analytical systems deployed at DEA laboratories around the country.

For more information on Waters products for UPLC, visit www.waters.com/uplc.

About Waters Corporation (www.waters.com)

For 50 years, Waters Corporation (NYSE: WAT) creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.58 billion in 2008 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, ACQUITY, UPLC, UltraPerformance LC, and ACQUITY UPLC are trademarks of Waters Corporation.


'/>"/>
SOURCE Waters Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. elephantjournal.com: Is Fluoridating Waters Giving Kids Cavities?
2. Video: Waters Highlights Impact of ACQUITY UPLC with Peer-to-Peer Scientist Testimonials
3. InVitria Headlines Sponsorship of WilBio's Waterside Conference
4. Waters Corporation Announces the Purchase of UPLC/MS Systems by the National Cancer Institute for Advanced Metabolomics Research
5. Red Cross Readies Shelters As Flood Waters Threaten to Top Levees
6. American Lung Association of Upper Midwest Offers Tips on Dealing With Floodwaters
7. AWWA partners with WaterSmart Innovations conference
8. Waters and LabVantage Partnership Targets Laboratory Informatics Integration to Maximize Data Management and Quality of Work
9. Next Generation Waters Successfully Reaches Over 300 Stores!
10. Leading Spring Water Brands From Nestle Waters Team Up With the American Heart Association START! Initiative
11. Waters To Unveil Xevo TQ MS Applications for Improved Drug Discovery at AAPS 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at Moffitt ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in an ... and sleep monitoring solutions for the global scientific community. The company’s new CentrePoint ...
(Date:4/28/2017)... ... 28, 2017 , ... NuevaCare, a leading home care agency based in San ... Alto, is proud to announce information upgrades to its blog in the form of ... on topics such as home care (generally) as well as senior care and home ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... hospital, based in Denver, Colorado, announced an agreement to create the Jane and ... support of the Jane and Leonard Korman Family Foundation. The collaboration leverages the ...
(Date:4/27/2017)... ... April 27, 2017 , ... The American ... 2017 Public Leadership in Neurology Award (PLINA). The couple joins a prestigious list ... Vice President Walter Mondale, actor Michael J. Fox and former U.S. Attorney General ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of its ... times purer and more potent than the market has seen before. Swissx uses proprietary ... well as a patented chromatography process for extraction, to produce its CBD oil--maximizing its ...
Breaking Medicine News(10 mins):
(Date:4/25/2017)... 2017 Endo International plc (NASDAQ: ENDP ) ... of its senior management team will host a conference call and ... The dial-in number to access the call is ... the passcode is 6086379. Please dial in 10 minutes prior to ... replay of the call will be available from May 9, 2017 ...
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, Inc. ... on providing the Urology, Uro/Gyn and Gynecology markets ... Ash Keswani has joined the Company as Senior ... newly created position, Mr. Keswani will report directly ... "Our organization is delighted that Ash ...
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
Breaking Medicine Technology: